← All companies

HQL

Abrdn Life Sciences Investors

HQL NYSE EDGAR ↗

$19.27

-0.17 -0.87%

Key statistics

from XBRL data in SEC filings

Market cap

—

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$13.05 – $21.32

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Changed accountants Sep 12, 2023 8-K Other events Mar 25, 2013 8-K Other events Mar 23, 2012 8-K Other events Jun 30, 2011 8-K Other events May 3, 2011 8-K Other events Nov 2, 2010 8-K Other events Apr 6, 2010 8-K Other events Sep 30, 2009 8-K Other events Aug 4, 2009 8-K Other events Jul 18, 2008

Other filings

4 OWNERSHIP DOCUMENT Jul 20, 2026 3 OWNERSHIP DOCUMENT Jun 11, 2026 N-CSRS Jun 8, 2026 NPORT-P May 29, 2026 DEF 14A Apr 7, 2026 SCHEDULE 13G/A Mar 6, 2026 NPORT-P Feb 27, 2026 SCHEDULE 13D/A Feb 23, 2026 SCHEDULE 13D/A Feb 11, 2026 SCHEDULE 13D/A Jan 8, 2026 3 OWNERSHIP DOCUMENT Dec 19, 2025 4 OWNERSHIP DOCUMENT Dec 18, 2025 N-CSR Dec 8, 2025 N-CEN Dec 8, 2025 NPORT-P Nov 26, 2025 SCHEDULE 13D/A Nov 24, 2025 SCHEDULE 13D/A Sep 26, 2025 4 PRIMARY DOCUMENT Sep 23, 2025 4 PRIMARY DOCUMENT Sep 19, 2025 4 PRIMARY DOCUMENT Sep 17, 2025 4 PRIMARY DOCUMENT Sep 15, 2025 4 PRIMARY DOCUMENT Sep 4, 2025 SCHEDULE 13D/A Sep 3, 2025 4 PRIMARY DOCUMENT Sep 2, 2025 N-PX Aug 29, 2025 NPORT-P Aug 28, 2025 4 PRIMARY DOCUMENT Aug 27, 2025 4 PRIMARY DOCUMENT Aug 25, 2025 40-17G Jul 29, 2025 3 OWNERSHIP DOCUMENT Jul 22, 2025